Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
2
×
clinical trials
life sciences
national blog main
national top stories
alirocumab
ally bridge group
alnylam pharmaceuticals
amgen
big data analytics
blackrock
boston
casdin capital
deals
diabetic nephropathy
eventide asset management
evolocumab
fda
focal segmental glomerulosclerosis
goldfinch bio
inclisiran
irving investors
jay ghosh
new york
new york blog main
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sanofi
schroeder adveq
software
the medicines company
third rock ventures
wellington management company
yonjin capital
What
company
2
×
drug
2
×
medicines
new
2
×
acquire
agreed
analysis
billion
bio
biotech
bring
brings
cash
cholesterol
compound
deal
develop
diseases
employing
fda
genetic
goldfinch
ipo
kidney
later
lead
medco
million
novartis
poised
raised
raises
ready
studies
wave
Language
unset
Current search:
drug
×
company
×
new
×
" boston top stories "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B